ExpreS2 platform licensed by Boston Children’s Hospital

The execution with Boston Children’s Hospital, located in Boston, Massachusetts, USA, of a non-exclusive research license agreement to use ExpreS2ion’s proprietary recombinant protein expression platform ExpreS2 for Boston Children’s academic research. Boston Children’s is the pediatric teaching affiliate of Harvard Medical School.

Read the PR